Concepts (355)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cryopreservation | 68 | 2023 | 103 | 9.790 |
Why?
|
| Cryoprotective Agents | 22 | 2022 | 31 | 5.680 |
Why?
|
| Heart Valves | 24 | 2022 | 171 | 4.210 |
Why?
|
| Organ Preservation | 20 | 2023 | 69 | 3.490 |
Why?
|
| Organ Preservation Solutions | 14 | 2022 | 45 | 2.700 |
Why?
|
| Vitrification | 6 | 2022 | 6 | 2.390 |
Why?
|
| Ice | 9 | 2022 | 13 | 1.780 |
Why?
|
| Cell Survival | 30 | 2022 | 901 | 1.690 |
Why?
|
| Animals | 79 | 2023 | 20881 | 1.190 |
Why?
|
| Dimethyl Sulfoxide | 13 | 2019 | 30 | 1.010 |
Why?
|
| Swine | 20 | 2023 | 672 | 1.000 |
Why?
|
| Insulin-Secreting Cells | 2 | 2016 | 41 | 0.950 |
Why?
|
| Cartilage, Articular | 4 | 2023 | 38 | 0.910 |
Why?
|
| Pancreas | 2 | 2016 | 225 | 0.890 |
Why?
|
| Tissue Preservation | 11 | 2023 | 44 | 0.860 |
Why?
|
| Heart Valve Prosthesis | 6 | 2019 | 222 | 0.830 |
Why?
|
| Freezing | 11 | 2023 | 29 | 0.800 |
Why?
|
| Trehalose | 2 | 2012 | 3 | 0.790 |
Why?
|
| Bioprosthesis | 5 | 2019 | 101 | 0.750 |
Why?
|
| Heart Transplantation | 2 | 2022 | 328 | 0.670 |
Why?
|
| Tissue Engineering | 9 | 2022 | 212 | 0.650 |
Why?
|
| Cell Line | 9 | 2016 | 1752 | 0.590 |
Why?
|
| Collagen | 9 | 2017 | 636 | 0.580 |
Why?
|
| Endothelium, Vascular | 13 | 2012 | 371 | 0.580 |
Why?
|
| Transplantation, Homologous | 14 | 2012 | 242 | 0.560 |
Why?
|
| Perfusion | 3 | 2022 | 131 | 0.540 |
Why?
|
| Saphenous Vein | 7 | 1993 | 61 | 0.540 |
Why?
|
| Jugular Veins | 6 | 2000 | 37 | 0.510 |
Why?
|
| Transplantation Immunology | 1 | 2014 | 11 | 0.490 |
Why?
|
| Organ Transplantation | 3 | 2017 | 110 | 0.490 |
Why?
|
| Heterografts | 1 | 2014 | 70 | 0.480 |
Why?
|
| Mammals | 2 | 2010 | 47 | 0.460 |
Why?
|
| Muscle, Smooth, Vascular | 10 | 2010 | 317 | 0.460 |
Why?
|
| Aortic Valve | 7 | 2004 | 249 | 0.450 |
Why?
|
| Regenerative Medicine | 3 | 2022 | 17 | 0.440 |
Why?
|
| Veins | 7 | 2000 | 68 | 0.430 |
Why?
|
| Formamides | 4 | 2019 | 4 | 0.430 |
Why?
|
| Disaccharides | 2 | 2022 | 9 | 0.420 |
Why?
|
| Kidney | 4 | 2006 | 945 | 0.410 |
Why?
|
| Calcinosis | 4 | 2004 | 241 | 0.410 |
Why?
|
| Temperature | 7 | 2023 | 341 | 0.410 |
Why?
|
| Blood Vessel Prosthesis | 6 | 2010 | 182 | 0.410 |
Why?
|
| Electroporation | 1 | 2010 | 11 | 0.380 |
Why?
|
| Dogs | 13 | 2010 | 490 | 0.370 |
Why?
|
| beta-Galactosidase | 1 | 2010 | 88 | 0.370 |
Why?
|
| Organ Specificity | 1 | 2010 | 167 | 0.360 |
Why?
|
| Glutathione | 3 | 2022 | 343 | 0.350 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2010 | 144 | 0.340 |
Why?
|
| Tissue Survival | 6 | 2017 | 22 | 0.340 |
Why?
|
| Pulmonary Valve | 3 | 2019 | 40 | 0.330 |
Why?
|
| Time Factors | 16 | 2019 | 4655 | 0.330 |
Why?
|
| Endothelial Cells | 1 | 2012 | 384 | 0.320 |
Why?
|
| Propylene Glycols | 3 | 2018 | 16 | 0.320 |
Why?
|
| Sus scrofa | 7 | 2017 | 74 | 0.320 |
Why?
|
| Magnetite Nanoparticles | 2 | 2019 | 28 | 0.320 |
Why?
|
| Cattle | 7 | 2014 | 475 | 0.310 |
Why?
|
| Preservation, Biological | 4 | 2016 | 11 | 0.310 |
Why?
|
| Cartilage | 1 | 2008 | 51 | 0.310 |
Why?
|
| Hot Temperature | 3 | 2018 | 152 | 0.300 |
Why?
|
| Immunity, Cellular | 2 | 2018 | 80 | 0.300 |
Why?
|
| Kidney Transplantation | 3 | 2006 | 839 | 0.290 |
Why?
|
| Humans | 38 | 2023 | 68618 | 0.280 |
Why?
|
| Rabbits | 8 | 2009 | 509 | 0.280 |
Why?
|
| Tissue Donors | 5 | 2022 | 195 | 0.280 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2008 | 333 | 0.270 |
Why?
|
| Acid-Base Equilibrium | 1 | 2006 | 10 | 0.270 |
Why?
|
| Hypothermia, Induced | 2 | 2005 | 93 | 0.260 |
Why?
|
| Heart Valve Prosthesis Implantation | 3 | 2017 | 164 | 0.260 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2017 | 124 | 0.260 |
Why?
|
| HEPES | 2 | 2018 | 2 | 0.250 |
Why?
|
| Sheep | 6 | 2019 | 128 | 0.240 |
Why?
|
| Tissue and Organ Procurement | 3 | 2010 | 164 | 0.240 |
Why?
|
| In Vitro Techniques | 7 | 2009 | 765 | 0.240 |
Why?
|
| Liver Function Tests | 1 | 2005 | 114 | 0.240 |
Why?
|
| Models, Animal | 5 | 2019 | 252 | 0.230 |
Why?
|
| Fructose-Bisphosphatase | 1 | 2004 | 2 | 0.230 |
Why?
|
| T-Lymphocytes | 2 | 2018 | 597 | 0.230 |
Why?
|
| Extracellular Fluid | 1 | 2004 | 29 | 0.230 |
Why?
|
| Biomechanical Phenomena | 7 | 2017 | 368 | 0.230 |
Why?
|
| Rats | 11 | 2014 | 5300 | 0.220 |
Why?
|
| Femoral Artery | 2 | 2001 | 139 | 0.210 |
Why?
|
| Ischemia | 2 | 2022 | 229 | 0.210 |
Why?
|
| Transplantation, Heterologous | 2 | 2014 | 122 | 0.210 |
Why?
|
| Gluconates | 1 | 2022 | 5 | 0.210 |
Why?
|
| Dextrans | 1 | 2022 | 33 | 0.210 |
Why?
|
| Cell Proliferation | 4 | 2017 | 1174 | 0.210 |
Why?
|
| Raffinose | 2 | 2016 | 28 | 0.200 |
Why?
|
| Mice | 5 | 2022 | 8474 | 0.200 |
Why?
|
| Allopurinol | 2 | 2016 | 36 | 0.200 |
Why?
|
| Extracellular Matrix | 4 | 2017 | 493 | 0.200 |
Why?
|
| Aorta | 4 | 2017 | 316 | 0.200 |
Why?
|
| Sucrose | 2 | 2018 | 58 | 0.190 |
Why?
|
| Acidosis, Renal Tubular | 1 | 2001 | 1 | 0.190 |
Why?
|
| Random Allocation | 3 | 2014 | 442 | 0.190 |
Why?
|
| Hypertonic Solutions | 1 | 2001 | 17 | 0.190 |
Why?
|
| Adenosine | 2 | 2016 | 165 | 0.190 |
Why?
|
| Fetus | 2 | 2012 | 157 | 0.190 |
Why?
|
| Monocytes | 3 | 2017 | 210 | 0.190 |
Why?
|
| Phase Transition | 1 | 2021 | 10 | 0.190 |
Why?
|
| Graft Survival | 6 | 2000 | 465 | 0.190 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2001 | 81 | 0.190 |
Why?
|
| Cell Hypoxia | 1 | 2001 | 92 | 0.190 |
Why?
|
| Carotid Artery, Common | 1 | 2000 | 25 | 0.180 |
Why?
|
| Allografts | 2 | 2019 | 63 | 0.180 |
Why?
|
| Solutions | 2 | 2013 | 115 | 0.180 |
Why?
|
| Chondrocytes | 2 | 2014 | 27 | 0.180 |
Why?
|
| Vascular Patency | 5 | 1993 | 122 | 0.170 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2000 | 49 | 0.170 |
Why?
|
| Insulin | 3 | 2016 | 619 | 0.170 |
Why?
|
| Serum | 2 | 2010 | 24 | 0.170 |
Why?
|
| Propylene Glycol | 1 | 2019 | 5 | 0.160 |
Why?
|
| Organ Culture Techniques | 2 | 2017 | 122 | 0.160 |
Why?
|
| Biocompatible Materials | 4 | 2012 | 247 | 0.160 |
Why?
|
| Male | 21 | 2017 | 37321 | 0.160 |
Why?
|
| Macrophages | 3 | 2017 | 647 | 0.160 |
Why?
|
| Crystallization | 1 | 2018 | 57 | 0.160 |
Why?
|
| Tissue Banks | 2 | 2015 | 13 | 0.150 |
Why?
|
| Postoperative Complications | 3 | 2004 | 1615 | 0.150 |
Why?
|
| Antifreeze Proteins | 2 | 2014 | 3 | 0.150 |
Why?
|
| Culture Media | 3 | 2014 | 155 | 0.150 |
Why?
|
| Aorta, Thoracic | 3 | 2012 | 211 | 0.140 |
Why?
|
| Cytokines | 3 | 2017 | 866 | 0.140 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2017 | 144 | 0.140 |
Why?
|
| Nanoparticles | 1 | 2019 | 254 | 0.140 |
Why?
|
| Electrophysiological Phenomena | 1 | 2016 | 20 | 0.140 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2012 | 618 | 0.130 |
Why?
|
| Biological Specimen Banks | 1 | 2015 | 38 | 0.130 |
Why?
|
| Tissue Culture Techniques | 2 | 2017 | 62 | 0.130 |
Why?
|
| Rats, Inbred Lew | 3 | 2005 | 150 | 0.130 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2017 | 306 | 0.130 |
Why?
|
| Stress, Mechanical | 2 | 2016 | 208 | 0.120 |
Why?
|
| Insect Proteins | 1 | 2014 | 4 | 0.120 |
Why?
|
| Coleoptera | 1 | 2014 | 8 | 0.120 |
Why?
|
| Epitopes | 1 | 2014 | 146 | 0.120 |
Why?
|
| Povidone | 1 | 1993 | 12 | 0.120 |
Why?
|
| Apoptosis | 3 | 2017 | 1641 | 0.110 |
Why?
|
| Carotid Arteries | 4 | 2017 | 110 | 0.110 |
Why?
|
| Hypothermia | 1 | 1994 | 37 | 0.110 |
Why?
|
| Fibroblasts | 4 | 2004 | 902 | 0.110 |
Why?
|
| alpha-Tocopherol | 1 | 2013 | 5 | 0.110 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2013 | 24 | 0.110 |
Why?
|
| Amphotericin B | 1 | 1993 | 26 | 0.110 |
Why?
|
| Ubiquinone | 1 | 2012 | 14 | 0.110 |
Why?
|
| Organophosphorus Compounds | 1 | 2012 | 13 | 0.110 |
Why?
|
| Cyclosporine | 1 | 1993 | 121 | 0.110 |
Why?
|
| Quinolines | 1 | 2013 | 48 | 0.110 |
Why?
|
| von Willebrand Factor | 1 | 2012 | 47 | 0.100 |
Why?
|
| Animal Testing Alternatives | 1 | 2012 | 5 | 0.100 |
Why?
|
| Kidney Tubules | 1 | 2012 | 80 | 0.100 |
Why?
|
| Oxazines | 1 | 2012 | 10 | 0.100 |
Why?
|
| Sodium Bicarbonate | 1 | 2012 | 5 | 0.100 |
Why?
|
| Xanthenes | 1 | 2012 | 18 | 0.100 |
Why?
|
| Glycoproteins | 1 | 1993 | 238 | 0.100 |
Why?
|
| Recombinant Proteins | 1 | 2014 | 742 | 0.100 |
Why?
|
| Aspirin | 1 | 1993 | 295 | 0.100 |
Why?
|
| RNA | 1 | 2012 | 171 | 0.100 |
Why?
|
| Muscle Contraction | 5 | 2006 | 210 | 0.100 |
Why?
|
| Calorimetry, Differential Scanning | 1 | 2011 | 27 | 0.100 |
Why?
|
| Drug Therapy, Combination | 1 | 1993 | 649 | 0.100 |
Why?
|
| Nature | 1 | 2010 | 2 | 0.100 |
Why?
|
| Heart | 2 | 2007 | 850 | 0.090 |
Why?
|
| Materials Testing | 1 | 2012 | 263 | 0.090 |
Why?
|
| Fluorescent Dyes | 1 | 2012 | 191 | 0.090 |
Why?
|
| Tunica Media | 1 | 2010 | 33 | 0.090 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 498 | 0.090 |
Why?
|
| Permeability | 3 | 2017 | 131 | 0.090 |
Why?
|
| Microscopy, Electron | 4 | 2007 | 351 | 0.090 |
Why?
|
| Species Specificity | 1 | 2009 | 303 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 2 | 1993 | 1026 | 0.080 |
Why?
|
| Microscopy, Interference | 1 | 2008 | 1 | 0.080 |
Why?
|
| Norepinephrine | 4 | 2000 | 276 | 0.080 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 3 | 2017 | 27 | 0.080 |
Why?
|
| Evaluation Studies as Topic | 3 | 1993 | 219 | 0.080 |
Why?
|
| Transplantation, Autologous | 3 | 2000 | 145 | 0.080 |
Why?
|
| Ferric Compounds | 2 | 2019 | 45 | 0.080 |
Why?
|
| Female | 11 | 2017 | 38074 | 0.080 |
Why?
|
| Mitochondria | 1 | 2012 | 643 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2000 | 1745 | 0.070 |
Why?
|
| Biomedical Research | 1 | 2010 | 310 | 0.070 |
Why?
|
| Elastin | 2 | 2017 | 116 | 0.070 |
Why?
|
| Kidney Function Tests | 1 | 2006 | 114 | 0.070 |
Why?
|
| Cells, Cultured | 4 | 2017 | 2673 | 0.070 |
Why?
|
| Bone Marrow Cells | 2 | 1986 | 217 | 0.070 |
Why?
|
| Buffers | 1 | 2006 | 31 | 0.070 |
Why?
|
| Reperfusion Injury | 1 | 1989 | 320 | 0.070 |
Why?
|
| Formaldehyde | 2 | 2017 | 48 | 0.060 |
Why?
|
| Feasibility Studies | 2 | 2006 | 652 | 0.060 |
Why?
|
| Lung | 1 | 2010 | 849 | 0.060 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2017 | 160 | 0.060 |
Why?
|
| Tissue Fixation | 2 | 2017 | 58 | 0.060 |
Why?
|
| Bile | 1 | 2005 | 35 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2004 | 2550 | 0.060 |
Why?
|
| Alanine Transaminase | 1 | 2005 | 137 | 0.060 |
Why?
|
| Transplantation, Isogeneic | 2 | 2003 | 19 | 0.060 |
Why?
|
| Islets of Langerhans | 1 | 2005 | 87 | 0.060 |
Why?
|
| Rats, Inbred BN | 1 | 2004 | 51 | 0.060 |
Why?
|
| Tunica Intima | 1 | 2004 | 59 | 0.060 |
Why?
|
| Renal Artery | 1 | 2004 | 29 | 0.060 |
Why?
|
| Hyperplasia | 1 | 2004 | 89 | 0.060 |
Why?
|
| Leukemia, Myeloid | 2 | 1993 | 39 | 0.060 |
Why?
|
| Cold Temperature | 2 | 1994 | 90 | 0.060 |
Why?
|
| Microdialysis | 1 | 2004 | 147 | 0.060 |
Why?
|
| Glycolysis | 1 | 2004 | 79 | 0.060 |
Why?
|
| Models, Cardiovascular | 1 | 2004 | 133 | 0.050 |
Why?
|
| Histamine | 2 | 2000 | 52 | 0.050 |
Why?
|
| Platelet Adhesiveness | 2 | 1993 | 20 | 0.050 |
Why?
|
| Refrigeration | 2 | 2014 | 7 | 0.050 |
Why?
|
| Glycine | 2 | 1993 | 89 | 0.050 |
Why?
|
| Tissue Transplantation | 1 | 2002 | 9 | 0.050 |
Why?
|
| Biomedical Engineering | 1 | 2002 | 20 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2023 | 2223 | 0.050 |
Why?
|
| Biophysics | 1 | 2002 | 41 | 0.050 |
Why?
|
| Glycerol | 1 | 2002 | 26 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 2 | 1993 | 852 | 0.050 |
Why?
|
| Bradykinin | 2 | 2000 | 157 | 0.050 |
Why?
|
| Angiotensin II | 2 | 2000 | 220 | 0.050 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2022 | 35 | 0.050 |
Why?
|
| Bioreactors | 1 | 2002 | 65 | 0.050 |
Why?
|
| Cell Death | 2 | 2012 | 329 | 0.050 |
Why?
|
| Pharmaceutical Vehicles | 1 | 2001 | 5 | 0.050 |
Why?
|
| Catalase | 1 | 2001 | 85 | 0.050 |
Why?
|
| Carbon Dioxide | 1 | 2001 | 78 | 0.050 |
Why?
|
| Glutamic Acid | 1 | 2004 | 332 | 0.050 |
Why?
|
| Lactic Acid | 1 | 2001 | 86 | 0.040 |
Why?
|
| Staining and Labeling | 1 | 2019 | 144 | 0.040 |
Why?
|
| Blood Vessels | 1 | 2000 | 102 | 0.040 |
Why?
|
| Heart Arrest | 1 | 2000 | 113 | 0.040 |
Why?
|
| Calcium | 1 | 2003 | 929 | 0.040 |
Why?
|
| Antioxidants | 1 | 2001 | 304 | 0.040 |
Why?
|
| Blood Transfusion | 1 | 2000 | 205 | 0.040 |
Why?
|
| Cell Differentiation | 2 | 2017 | 1034 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2004 | 1851 | 0.040 |
Why?
|
| Pandemics | 1 | 2022 | 352 | 0.040 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2018 | 38 | 0.040 |
Why?
|
| Vasodilation | 2 | 1996 | 85 | 0.040 |
Why?
|
| Hemodynamics | 2 | 2010 | 705 | 0.040 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 1999 | 186 | 0.040 |
Why?
|
| Osmolar Concentration | 1 | 2018 | 134 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2010 | 1174 | 0.040 |
Why?
|
| Diffusion | 1 | 2018 | 90 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2017 | 147 | 0.040 |
Why?
|
| Cell Culture Techniques | 2 | 2010 | 189 | 0.040 |
Why?
|
| Paraffin Embedding | 1 | 2017 | 47 | 0.040 |
Why?
|
| Thiones | 1 | 2017 | 16 | 0.040 |
Why?
|
| Fibrillar Collagens | 1 | 2017 | 49 | 0.040 |
Why?
|
| Convection | 1 | 2017 | 4 | 0.040 |
Why?
|
| Colloids | 1 | 2017 | 43 | 0.040 |
Why?
|
| Quinazolines | 1 | 2017 | 70 | 0.040 |
Why?
|
| Reference Standards | 1 | 2017 | 115 | 0.040 |
Why?
|
| Procollagen | 1 | 1997 | 31 | 0.040 |
Why?
|
| Elastic Modulus | 1 | 2016 | 25 | 0.030 |
Why?
|
| Tensile Strength | 1 | 2016 | 90 | 0.030 |
Why?
|
| Matrix Metalloproteinases | 1 | 2017 | 223 | 0.030 |
Why?
|
| Electric Conductivity | 1 | 2016 | 87 | 0.030 |
Why?
|
| Forecasting | 1 | 2017 | 277 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2018 | 384 | 0.030 |
Why?
|
| Cell Movement | 1 | 2017 | 630 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 1996 | 1040 | 0.030 |
Why?
|
| Hypoxanthines | 1 | 1993 | 6 | 0.030 |
Why?
|
| Hypoxanthine | 1 | 1993 | 8 | 0.030 |
Why?
|
| Radioisotope Dilution Technique | 1 | 1993 | 14 | 0.030 |
Why?
|
| Thrombophlebitis | 1 | 1994 | 47 | 0.030 |
Why?
|
| Chondroitin Sulfates | 1 | 1994 | 44 | 0.030 |
Why?
|
| Deoxyglucose | 1 | 1993 | 32 | 0.030 |
Why?
|
| Tritium | 1 | 1993 | 101 | 0.030 |
Why?
|
| Proline | 1 | 1993 | 52 | 0.030 |
Why?
|
| Glucose | 2 | 2006 | 307 | 0.030 |
Why?
|
| Molecular Weight | 1 | 1993 | 358 | 0.030 |
Why?
|
| Drug Synergism | 1 | 1993 | 260 | 0.030 |
Why?
|
| Vasoconstriction | 2 | 1991 | 81 | 0.030 |
Why?
|
| Nitrosation | 1 | 2012 | 2 | 0.030 |
Why?
|
| Water-Electrolyte Balance | 1 | 1993 | 43 | 0.030 |
Why?
|
| Electron Transport | 1 | 2012 | 37 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2012 | 63 | 0.030 |
Why?
|
| Cell Membrane | 1 | 1994 | 525 | 0.030 |
Why?
|
| Hemolysis | 1 | 2012 | 39 | 0.030 |
Why?
|
| Biomarkers | 1 | 2017 | 1593 | 0.030 |
Why?
|
| Disinfection | 1 | 1993 | 112 | 0.030 |
Why?
|
| Necrosis | 1 | 2012 | 239 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 1992 | 181 | 0.030 |
Why?
|
| Fungi | 1 | 1992 | 27 | 0.020 |
Why?
|
| Safety | 1 | 2012 | 145 | 0.020 |
Why?
|
| Blood Coagulation | 1 | 2012 | 123 | 0.020 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 1994 | 373 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 1992 | 172 | 0.020 |
Why?
|
| Antifungal Agents | 1 | 1992 | 108 | 0.020 |
Why?
|
| Computational Biology | 1 | 2012 | 190 | 0.020 |
Why?
|
| Graft Occlusion, Vascular | 1 | 1990 | 73 | 0.020 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2010 | 31 | 0.020 |
Why?
|
| Survival Analysis | 1 | 1992 | 714 | 0.020 |
Why?
|
| Bacteria | 1 | 1992 | 193 | 0.020 |
Why?
|
| Photons | 1 | 2010 | 32 | 0.020 |
Why?
|
| Fluorescence | 1 | 2010 | 104 | 0.020 |
Why?
|
| Reoperation | 1 | 1992 | 467 | 0.020 |
Why?
|
| Potassium Chloride | 1 | 1990 | 45 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2012 | 504 | 0.020 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2010 | 145 | 0.020 |
Why?
|
| Risk Factors | 1 | 2000 | 5731 | 0.020 |
Why?
|
| Vasodilator Agents | 1 | 2010 | 138 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2010 | 160 | 0.020 |
Why?
|
| Serotonin | 1 | 1990 | 144 | 0.020 |
Why?
|
| Proteins | 1 | 2012 | 474 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2010 | 201 | 0.020 |
Why?
|
| Survival Rate | 1 | 1991 | 1056 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2012 | 718 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 1992 | 848 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 2324 | 0.020 |
Why?
|
| Microscopy | 1 | 2007 | 64 | 0.020 |
Why?
|
| Granulocytes | 1 | 1986 | 22 | 0.020 |
Why?
|
| Papaverine | 1 | 2006 | 10 | 0.020 |
Why?
|
| Hematopoiesis | 1 | 1986 | 108 | 0.020 |
Why?
|
| Polyglycolic Acid | 1 | 2006 | 20 | 0.020 |
Why?
|
| Shear Strength | 1 | 2005 | 15 | 0.020 |
Why?
|
| Elasticity | 1 | 2005 | 103 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2010 | 2083 | 0.020 |
Why?
|
| Adult | 3 | 1992 | 21403 | 0.020 |
Why?
|
| Cell Division | 1 | 1986 | 541 | 0.020 |
Why?
|
| Fetal Tissue Transplantation | 1 | 2005 | 12 | 0.020 |
Why?
|
| Indicators and Reagents | 1 | 2005 | 63 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2006 | 324 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 1985 | 149 | 0.020 |
Why?
|
| Endothelin-1 | 1 | 2006 | 122 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 1991 | 3259 | 0.020 |
Why?
|
| Kinetics | 1 | 2005 | 1047 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 1985 | 245 | 0.010 |
Why?
|
| Adolescent | 2 | 1992 | 8912 | 0.010 |
Why?
|
| Vasoconstrictor Agents | 1 | 2000 | 107 | 0.010 |
Why?
|
| Intestines | 1 | 1999 | 114 | 0.010 |
Why?
|
| Pregnancy | 1 | 2005 | 2334 | 0.010 |
Why?
|
| Middle Aged | 2 | 1992 | 21147 | 0.010 |
Why?
|
| Aged | 1 | 1992 | 14862 | 0.010 |
Why?
|
| Nerve Endings | 1 | 1992 | 14 | 0.010 |
Why?
|
| Prostaglandins | 1 | 1992 | 65 | 0.010 |
Why?
|
| Logistic Models | 1 | 1996 | 1420 | 0.010 |
Why?
|
| Endothelins | 1 | 1992 | 57 | 0.010 |
Why?
|
| Cyclosporins | 1 | 1990 | 10 | 0.010 |
Why?
|
| Swine, Miniature | 1 | 1990 | 45 | 0.010 |
Why?
|
| Isoantibodies | 1 | 1990 | 35 | 0.010 |
Why?
|
| Major Histocompatibility Complex | 1 | 1990 | 34 | 0.010 |
Why?
|
| Histocompatibility Testing | 1 | 1990 | 38 | 0.010 |
Why?
|
| Blood Platelets | 1 | 1991 | 284 | 0.010 |
Why?
|
| Compliance | 1 | 1989 | 26 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 1992 | 382 | 0.010 |
Why?
|
| Epoprostenol | 1 | 1989 | 71 | 0.010 |
Why?
|
| Radiation Chimera | 1 | 1985 | 15 | 0.000 |
Why?
|
| Colony-Forming Units Assay | 1 | 1985 | 78 | 0.000 |
Why?
|
| Mice, Inbred Strains | 1 | 1985 | 181 | 0.000 |
Why?
|
| Bone Marrow | 1 | 1985 | 168 | 0.000 |
Why?
|
| Cardiac Surgical Procedures | 1 | 1988 | 450 | 0.000 |
Why?
|
| Hematopoietic Stem Cells | 1 | 1985 | 268 | 0.000 |
Why?
|
| Lipopolysaccharides | 1 | 1985 | 455 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1988 | 2455 | 0.000 |
Why?
|
| Infant | 1 | 1988 | 2891 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1988 | 3187 | 0.000 |
Why?
|
| Child | 1 | 1988 | 6405 | 0.000 |
Why?
|